Kisspeptin

What is Kisspeptin?

Kisspeptin is a naturally occurring peptide hormone, encoded by the KISS1 gene, that acts as a master regulator of the body's reproductive system. It was originally identified as a tumor-metastasis suppressor — hence its alternate name, metastin — before its central role in fertility and sex-hormone signaling was recognized. The forms studied clinically include the full-length peptide and shorter active fragments such as kisspeptin-10.

Rather than acting like a sex hormone itself, kisspeptin works upstream: it tells the brain when to switch the reproductive axis on. In the United States it is not an FDA-approved drug. Where it is used outside of formal research, it is prescribed only as a pharmacy-compounded preparation under physician supervision, and the human evidence base is still emerging — a point we make plainly to every patient who asks about it.

How Kisspeptin works

Kisspeptin binds the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, stimulating the release of gonadotropin-releasing hormone. GnRH in turn drives the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which signal the testes or ovaries to produce testosterone, estrogen, and to support egg and sperm development. In this sense kisspeptin sits one step above GnRH at the very top of the hypothalamic-pituitary-gonadal (HPG) axis.

Beyond its endocrine role, imaging research from Imperial College London has shown that kisspeptin also acts on limbic brain regions involved in sexual and emotional processing, enhancing activity in networks tied to arousal and attraction. This dual action — hormonal upstream of GnRH, and behavioral within the brain — is what makes it of research interest for both reproductive and libido-related applications.

What Kisspeptin is used for

What the evidence shows

The human evidence for kisspeptin is genuinely emerging rather than established. A series of controlled studies from Imperial College London, using functional MRI, found that administering kisspeptin to men and to women with low sexual desire increased activity in brain networks governing sexual and emotional processing, and in some cases improved self-reported measures of arousal and mood [1][2].

Its role at the top of the reproductive axis is well characterized physiologically: kisspeptin reliably raises LH, FSH, and downstream sex hormones, and has been used experimentally to trigger egg maturation in fertility protocols [3]. What does not yet exist is a body of large, long-term randomized trials establishing efficacy and safety for libido or hormonal use as a prescribed therapy.

We present this honestly. Kisspeptin is a biologically compelling target with real, peer-reviewed human data behind its mechanism — but it remains investigational, and anyone considering it should understand that they are choosing an early-stage compound, not a proven, FDA-approved treatment.

Dosing & administration context

In research settings kisspeptin has been given by injection — including single subcutaneous doses and continuous infusions — with the form (full-length versus kisspeptin-10) and schedule varying by study aim. There is no standardized, validated therapeutic protocol for libido or hormonal use, which is part of why it remains investigational.

Any use outside of a formal trial is individualized by the prescribing physician, and we frame this strictly as clinical context rather than a self-dosing guide. Kisspeptin obtained from research-only vials or gray-market sources carries no guarantee of identity, purity, or sterility, and self-administration of a compound this early in its clinical evidence is something we specifically advise against.

Kisspeptin is not an FDA-approved medication and remains investigational. Content on this page is clinical context for physician-supervised, pharmacy-compounded use — not a dosing guide or a substitute for medical advice.

Safety & side effects

In the controlled human studies conducted to date, kisspeptin has generally been well tolerated, with no consistent pattern of serious adverse effects reported at the doses used. Because it works by stimulating the body's own hormonal axis rather than flooding it with an external hormone, its short-term profile in research has been reassuring.

That said, the long-term safety of repeated or ongoing use is simply not established — the trials have been short and the treated populations small. We screen carefully before considering it, monitor hormones and symptoms throughout, and are candid that source control (a licensed 503A/503B compounding pharmacy versus an unknown vial) is a fundamental part of the risk picture.

How Strong Health prescribes Kisspeptin

At Strong Health, kisspeptin is approached conservatively and only after a physician evaluation that includes a review of your reproductive and hormonal history and, where relevant, baseline labs. Given how early the human evidence is, we set expectations explicitly and make sure any candidate understands its investigational status before proceeding.

Where it is used, it is dispensed only through licensed 503A or 503B compounding pharmacies under physician orders — never research-only product — and treated as one part of a monitored plan rather than a standalone fix. Your physician defines the protocol, reviews your response at scheduled intervals, and adjusts or stops treatment based on how you actually respond.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions